SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-034436
Filing Date
2009-08-13
Accepted
2009-08-13 10:52:11
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b76235oie10vq.htm 10-Q 361716
2 EX-3.1 CERTIFICATE OF AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF INCORPO b76235oiexv3w1.htm EX-3.1 6361
3 EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b76235oiexv31w1.htm EX-31.1 5774
4 EX-31.2 SECTION 302 CERTIFICATION OF VICE PRESIDENT AND CHIEF FINANCIAL OFFICER b76235oiexv31w2.htm EX-31.2 6123
5 EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL b76235oiexv32w1.htm EX-32.1 3571
  Complete submission text file 0000950123-09-034436.txt   384955
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 091008860
SIC: 2836 Biological Products, (No Diagnostic Substances)